Samsung Medical Center

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Subsidiary

Established: 1994-01-01

Employees: 501

Market Cap: -

Website: http://www.samsunghospital.com

Clinical Trials

A Phase II Clinical Trial of Reduced Port Totally Laparoscopic Distal Gastrectomy With D2 Lymph Node Dissection

Phase 2

Conditions: Gastric Cancer

Interventions: Procedure: reduced port laparoscopic distal gastrectomy

First Posted Date: 2014-12-08

Last Posted Date: 2014-12-08

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 67

Registration Number: NCT02311595

Prompt Or Watchful Monitoring for Hepatitis B Virus Related Hepatocellular Carcinoma Without Elevated viRal Load

Phase 4

Conditions: Carcinoma, Hepatocellular

Interventions: Drug: Tenofovir disoproxil fumarate

First Posted Date: 2014-12-04

Last Posted Date: 2014-12-04

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 124

Registration Number: NCT02308319

Evaluation of EV1000™/volumeView™ for Cardiac Output Monitoring in Liver Transplantation

Completed

Conditions: Liver Disease

Interventions: Device: EV1000™/volumeView™

First Posted Date: 2014-12-03

Last Posted Date: 2016-05-10

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 28

Registration Number: NCT02306018

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

The Screening Protocol for The VIKTORY Trial

Not Applicable

Completed

Conditions: Stomach Neoplasms

Interventions: Other: Molecular profiling

First Posted Date: 2014-11-24

Last Posted Date: 2022-06-15

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 651

Registration Number: NCT02299648

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
🇰🇷
Samsung Medical center, Seoul, Korea, Republic of

Personalized Sequence for Thoracic, Esophageal, and H&N Cancer

Conditions: Lung Cancer

First Posted Date: 2014-11-24

Last Posted Date: 2021-03-19

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 200

Registration Number: NCT02299622

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Hyaluronidase for Trigger Point Injection in Myofascial Pain Syndrome

Not Applicable

Completed

Conditions: Myofascial Pain Syndrome

Interventions: Drug: trigger point injection

First Posted Date: 2014-11-18

Last Posted Date: 2014-11-18

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 61

Registration Number: NCT02293083

Efficacy of NeoThermo-Radio-chemotherapy for LA Rectal Cancer Before Laparoscopic TME: Prospective Phase II Trial

Not Applicable

Terminated

Conditions: Locally Advanced Rectal Cancer

Interventions: Radiation: Hyperthermia with concurrent chemo-radiation therapy

First Posted Date: 2014-11-14

Last Posted Date: 2019-11-01

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 14

Registration Number: NCT02290574

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Transarterial Chemoembolization (TACE) With Radiation Therapy (RT) in Advanced Hepatocellular Carcinoma (HCC)

Phase 2

Conditions: Hepatocellular Carcinoma
Portal Vein Tumor Thrombosis

Interventions: Radiation: Scheduled interval TACE - RT

First Posted Date: 2014-11-14

Last Posted Date: 2014-12-05

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 40

Registration Number: NCT02290977

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Brentuximab Vedotin for Relapsed/Refractory CD30-positive Non-Hodgkin Lymphomas

Phase 2

Completed

Conditions: Non-Hodgkin Lymphoma

Interventions: Drug: Brentuximab vedotin

First Posted Date: 2014-11-02

Last Posted Date: 2018-09-06

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 33

Registration Number: NCT02280785

Locations: 🇰🇷
Korean Cancer Center Hospital, Seoul, Korea, Republic of
🇰🇷
National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of
🇰🇷
Yonsei Severance Hospital, Seoul, Korea, Republic of

and more 1 locations

Evaluation of SVV From NICOM as a Predictor of Fluid Responsiveness in Prone Position During Spine Surgery

Completed

Conditions: Fluid Responsiveness
Non Invasive Cardiac Output Monitoring
Prone Position

Interventions: Other: Fluid loading to evaluate fluid responsiveness

First Posted Date: 2014-10-29

Last Posted Date: 2015-07-21

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 40

Registration Number: NCT02277353

Locations: 🇰🇷
Samsung Seoul Hospital, Samsung Medical Center, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy